沃里康纳引起的中枢神经系统毒性:基于FDA不良事件报告系统 (FAERS) 数据库的药监测研究
Juping Yun1, Zihe Wang1, Wei Liu1
1Beijing You'an Hospital, Capital Medical University, Beijing, China.
Expert opinion on drug safety
|August 12, 2024
概括
沃里科纳 (VRC) 与中枢神经系统 (CNS) 毒性有关,包括精神病和眼睛疾病. 剂量调整和治疗药物监测等策略可以减轻VRC.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
背景情况:
- 沃里康纳 (VRC) 是一种抗真菌药物.
- 中枢神经系统 (CNS) 毒性是VRC的潜在不良影响之一.
- 现实世界的数据分析对于了解VRC的安全概况至关重要.
研究的目的:
- 评估voriconazole (VRC) 与中枢神经系统 (CNS) 毒性之间的关联.
- 为了确定与VRC相关的特定的中枢神经系统相关的不良事件.
- 将VRC的中枢神经系统毒性风险与其他醇抗真菌药物进行比较.
主要方法:
- 利用了来自FAERS数据库的数据 (2004年1月 - 2022年3月).
- 使用医学监管活动词典 (MedDRA) 术语识别的中枢神经系统毒性事件.
- 雇员报告几率 (ROR) 使用95%的置信区间 (CI) 来量化与VRC相关的CNS事件信号.
主要成果:
- 沃里康纳与精神疾病 (ROR 1.84),神经系统疾病 (ROR 1.09) 和眼睛疾病 (ROR 3.84) 有显著的关联.
- 中枢神经系统事件发生的中位时间为1天.
- 关键的VRC相关的眼睛事件包括斑点不透明,叶绿和有毒的视神经病变.
结论:
- 沃里康纳与中枢神经系统毒性显著相关,特别是精神病和眼睛疾病.
- 建议采用个性化药物策略,包括剂量调整和治疗药物监测,以提高VRC的疗效和减少不良事件.
相关概念视频
Pharmacovigilance
801
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
801
Local Anesthetics: Adverse Effects
401
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
401
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
156
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
156
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
240
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
240
Anticholinesterase Agents: Poisoning and Treatment
820
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
820
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
186
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
186


